TWN Info Service on Health Issues (2019)

• Access to Biotherapeutics undermined by WHO Expert Committee
  by K M Gopakumar & Chetali Rao (13 Dec 19)
• Facilitating Access to New Biologic Medicines - call to update the WHO Guidelines on Similar Biotherapeutic products
  (24 Oct 19)
• Submission on 2009 Similar Biotherapeutic Products Guidelines review
  (23 Oct 19)
• MSF launches global campaign to lower price of crucial TB drug
  by Kanaga Raja (16 Oct 19)
• R&D costs and pricing of medicines & health technologies
  by Kanaga Raja (14 Oct 19)
• Turkey's measures on pharmaceutical products for dispute panel
  by Kanaga Raja (03 Oct 19)
• New IPCC report warns of ocean warming and dire impacts
  by Indrajit Bose (30 Sept 19)
• CSO Letter to RCEP Negotiators on Intellectual Property
  (25 Sept 19)
• IPHU Course Announcement: The Struggle for Health and Access to Affordable Medicines - Cape Town (November, 2019)
  (01 Aug 19)
• Access to medicines fundamental to enjoyment of health
  by Kanaga Raja (16 Jul 19)
• Press release: Sustainable development needs fundamental governance changes
  (09 Jul 19)
• WIPO: Compulsory License a crucial public policy tool, say developing countries
  by Prathibha Sivasubramaniam & Sangeeta Shashikant (05 Jul 19)
• TWN Policy Brief on Patents and Pre-Grant Opposition in India
  by Veena Johari, K M Gopakumar & Arundhati Abhyankar (03 Jul 19)
• 60 CSOs demand ARIPO reform to increase access to medicines in Africa
  (26 Jun 19)
• WHO: Nagoya Protocol Decision Asks WHO to Report on Current Pathogen-Sharing Modalities
  by TWN (11 Jun 19)
• WHO: Countries Raise Concerns about Access to Affordable Drug-Resistant TB Treatment
  by TWN (10 Jun 19)
• WHO: Member States adopt resolution on transparency in medicine pricing
  by K M Gopakumar (30 May 19)
• WHO: Consensus on transparency resolution still elusive
  by Heba Wanis & K M Gopakumar (30 May 19)
• Primary health care is where battle for health will be won or lost
  by Kanaga Raja (29 May 19)
• WHO: Stepping up antimicrobial resistance action
  by Heba Wanis (27 May 19)
• Biosimilars - Civil Society Letter to the WHO Director General
  (23 May 19)
• Ebola: Company avoids benefit-sharing obligation by using sequences (French-language version)
  by Edward Hammond (15 May 19)
• Ebola: Company avoids benefit-sharing obligation by using sequences
  by Edward Hammond (15 May 19)
• WHO's Reluctance to implement WHA Resolution Affects Access to Affordable Biotherapeutics
  by Chetali Rao & K M Gopakumar (13 May 19)
• Civil Society Open Letter to World Health Assembly Delegates on Transparency Resolution Negotiations
  (10 May 19)
• Letter to India's Health Minister: Bedaquiline donations threaten sustainable, affordable access for patients; Create conflict of interest
  (09 May 19)
• United Nations: US sanctions on Cuba, Venezuela violate human rights
  by Kanaga Raja (09 May 19)
• Revise Biosimilar Guidelines, Scientists Demand; WHO Says Not Now
  by William New (08 May 19)
• New APBREBES Publication: A Dysfunctional Plant Variety Protection System: Ten Years of UPOV Implementation in Francophone Africa
  by Mohamed Coulibaly, Robert Ali Brac de la Perrière, with contributions from Sangeeta Shashikant (29 Apr 19)
• WHO: Restructuring fails to address conflict of interest in FENSA Implementation
  by K M Gopakumar (24 Apr 19)
• WHO: No "Fair Price" without access and transparency, say CSOs
  by TWN (22 Apr 19)
• WIPO: Generic industry calls for review of WIPO involvement in Pat-INFORMED
  by TWN (17 Apr 19)
• Deadly fungal infection spreading globally in secrecy
  (11 Apr 19)
• Pathogens hitchhiking on plastics could carry diseases worldwide
  (04 Apr 19)
• Report: Zoonoses and antimicrobial resistance ring alarm bells
  (01 Apr 19)
• Europe: Report highlights challenges in fight to end TB
  (28 Mar 19)
• WHO recommends oral regimes to treat MDR-TB
  (26 Mar 19)
• Antibiotic-resistant genes found in one of the most remote places on Earth
  (22 Mar 19)
• WHO: Will PIP Framework's "Equal Footing" Principle Be Undermined & Pandemic Preparedness Threatened?
  by TWN (20 Mar 19)
• Investment Protection Proposals Under RCEP Threaten India's Pharma Industry
  by Prathibha Sivasubramanian (18 Mar 19)
• Patent protection not at the cost of local manufacture
  by K. M. Gopakumar (18 Feb 19)
• WHO backs South Africa's TRIPS proposal on public health
  by D. Ravi Kanth (12 Feb 19)
• Draft Patents Rules Undermine Safeguards Against Frivolous Patents
  by K. M. Gopakumar (22 Jan 19)